Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 11, 2020 04:38PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Stockwatch shows the following: It's a Capital Pool Company that raises capital for businesses.
https://www.stockwatch.com/News/Item?bid=Z-C:ZENI-2874435&symbol=ZENI®ion=C
Koo